Literature DB >> 31066863

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.

Patrizio Lancellotti1,2, Lucia Musumeci1, Nicolas Jacques1, Laurence Servais1, Eric Goffin1,3, Bernard Pirotte3, Cécile Oury1.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31066863      PMCID: PMC6506905          DOI: 10.1001/jamacardio.2019.1189

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  6 in total

Review 1.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

2.  Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.

Authors:  Renli Teng; Stuart Oliver; Martin A Hayes; Kathleen Butler
Journal:  Drug Metab Dispos       Date:  2010-06-15       Impact factor: 3.922

3.  From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

Authors:  Brian Springthorpe; Andrew Bailey; Patrick Barton; Timothy N Birkinshaw; Roger V Bonnert; Roger C Brown; David Chapman; John Dixon; Simon D Guile; Robert G Humphries; Simon F Hunt; Francis Ince; Anthony H Ingall; Ian P Kirk; Paul D Leeson; Paul Leff; Richard J Lewis; Barrie P Martin; Dermot F McGinnity; Michael P Mortimore; Stuart W Paine; Garry Pairaudeau; Anil Patel; Aaron J Rigby; Robert J Riley; Barry J Teobald; Wendy Tomlinson; Peter J H Webborn; Paul A Willis
Journal:  Bioorg Med Chem Lett       Date:  2007-08-19       Impact factor: 2.823

4.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

5.  Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study.

Authors:  Robert F Storey; Stefan K James; Agneta Siegbahn; Christoph Varenhorst; Claes Held; Joseph Ycas; Steen E Husted; Christopher P Cannon; Richard C Becker; Ph Gabriel Steg; Nils Åsenblad; Lars Wallentin
Journal:  Platelets       Date:  2013-10-15       Impact factor: 3.862

6.  Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia.

Authors:  Travis R Sexton; Guoying Zhang; Tracy E Macaulay; Leigh A Callahan; Richard Charnigo; Olga A Vsevolozhskaya; Zhenyu Li; Susan Smyth
Journal:  JACC Basic Transl Sci       Date:  2018-08-28
  6 in total
  26 in total

Review 1.  A Comprehensive Review of the Pleiotropic Effects of Ticagrelor.

Authors:  Jeffrey Triska; Neil Maitra; Matthew R Deshotels; Faris Haddadin; Dominick J Angiolillo; Gemma Vilahur; Hani Jneid; Dan Atar; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-08-24       Impact factor: 3.947

2.  Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?

Authors:  Ahmad Mourad; Thomas L Holland; Nicholas A Turner
Journal:  Antimicrob Agents Chemother       Date:  2022-05-10       Impact factor: 5.938

Review 3.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

4.  Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia.

Authors:  Erlinda R Ulloa; Satoshi Uchiyama; Robert Gillespie; Victor Nizet; George Sakoulas
Journal:  J Infect Dis       Date:  2021-11-16       Impact factor: 5.226

5.  Risk of Pneumonia with Ticagrelor Versus Clopidogrel: a Population-Based Cohort Study.

Authors:  Ricky D Turgeon; Erik Youngson; Michelle M Graham
Journal:  J Gen Intern Med       Date:  2020-08-20       Impact factor: 6.473

6.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

Authors:  Jeffrey S Berger; Lucy Z Kornblith; Michelle N Gong; Harmony R Reynolds; Mary Cushman; Yu Cheng; Bryan J McVerry; Keri S Kim; Renato D Lopes; Bassel Atassi; Scott Berry; Grant Bochicchio; Murillo de Oliveira Antunes; Michael E Farkouh; Yonatan Greenstein; Erinn M Hade; Kristin Hudock; Robert Hyzy; Pooja Khatri; Andrei Kindzelski; Bridget-Anne Kirwan; Lisa Baumann Kreuziger; Patrick R Lawler; Eric Leifer; Jose Lopez-Sendon Moreno; Jose Lopez-Sendon; James F Luther; Lilia Nigro Maia; John Quigley; Robert Sherwin; Lana Wahid; Jennifer Wilson; Judith S Hochman; Matthew D Neal
Journal:  JAMA       Date:  2022-01-18       Impact factor: 157.335

7.  Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps.

Authors:  Alexandros Mitsios; Akrivi Chrysanthopoulou; Athanasios Arampatzioglou; Iliana Angelidou; Veroniki Vidali; Konstantinos Ritis; Panagiotis Skendros; Dimitrios Stakos
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

8.  Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction

Authors:  Ercan Akşit; Bahadır Kırılmaz; Emine Gazi; Fatih Aydın
Journal:  Balkan Med J       Date:  2020-04-24       Impact factor: 2.021

Review 9.  Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era.

Authors:  Kunal Mahajan; Aditya Batra
Journal:  Indian Heart J       Date:  2020-05-23

Review 10.  Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies.

Authors:  Alexander J Rodríguez; Bo Abrahamsen
Journal:  JBMR Plus       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.